Document:

<PAGE>
                                                                   Exhibit 10.12

                               INDEMNITY AGREEMENT

                  This Indemnity Agreement is made this ___ day of , 200_, by
and between BioVeris Corporation, a Delaware corporation (the "Company"), and
____________, (the "Indemnitee").

                                   WITNESSETH:

                  WHEREAS, the Company and the Indemnitee desire to enter into
this Agreement, which is intended to replace any indemnification agreement that
may exist between the Indemnitee and the Company.

                  NOW, THEREFORE, the Company and the Indemnitee for good and
valuable consideration, the receipt of which is hereby acknowledged, hereby
agree as follows:

               1. Definitions.  Capitalized terms used herein shall have the
meaning as set forth below:

                  (a) "Claim" shall mean any threatened, pending or completed
claim, action, demand, suit or proceeding, whether civil, criminal,
administrative or investigative, and whether formal or informal.

                  (b) "Damages" shall mean any losses, liabilities, damages or
any nature (including consequential, special and incidental), claims, demands,
judgments, amounts paid in settlements, fines, penalties, expenses and costs,
ERISA excise taxes. Without limiting the generality of the foregoing, Damages
shall include any and all Defense Costs.

                  (c) "Defense Costs" shall mean any costs, charges, bonds,
fees, expenses, including reasonable attorneys' fees and fees of experts,
consultants, witnesses and court costs, incurred in the investigation, defense
or prosecution of any Claim.

                  (d) "Final Adjudication" shall mean final judicial decision
in a court of competent jurisdiction from which there is no further right to
appeal.

                  (e) "Person" shall mean any individual, partnership, limited
partnership, corporation, company association, business trust, employee benefit
or retirement plan or trust, limited liability company, trust unincorporated
association, joint venture, enterprise of any nature (whether incorporated or
unincorporated) that is capable of suing or being sued or that is recognized or
recognizable in a court of law or equity as a "person", or any government
entity, authority or agency.

                  (f) "Third Party" shall mean any trustee, receiver, creditor,
contractor, vendor, insurance carrier, service provider to the Company or any
other person doing business or otherwise associated with the Company in any
capacity.

                  (g)      "Undertaking" shall have the meaning as set forth in
Section 3.

<PAGE>

         2. Right to Indemnification. The Company shall defend, indemnify and
hold harmless the Indemnitee from and against any and all Damages asserted
against or suffered or incurred by the Indemnitee in connection with any Claim
brought by any Person, including any Third Party, in respect of, relating to,
or by reason of the fact that the Indemnitee is or was a director, officer,
manager, employee, agent or representative of the Company or is or was serving
at the request of the Company as a director, officer, manager, employee or agent
of another Person, whether the basis of such Claim is alleged action or inaction
in an official capacity as a director, officer, manager, employee, agent or
representative or in any other capacity while serving as a director, officer,
manager, employee, agent or representative, to the fullest extent permitted by
applicable law, as the same exists or may hereafter be amended (but, in the case
of any such amendment, only to the extent that such amendment permits the
Company to provide broader indemnification rights than permitted prior thereto),
and such indemnification shall continue after the Indemnitee has ceased to be a
director, officer, manager, employee agent or representative and shall inure to
the benefit of the Indemnitee's heirs, executors, trustees and administrators;
provided, however, that, except as provided in Section 4 hereof with respect to
proceedings to enforce rights to indemnification and advancement of Defense
Costs, the Company shall indemnify the Indemnitee in connection with any Claim
(or part thereof) initiated by the Indemnitee only if such Claim (or part
thereof) was authorized by the board of directors of the Company.

         3. Right to Advancement of Defense Costs. In addition to the right to
indemnification conferred in Section 2 hereof, the Indemnitee shall have the
right to be paid by the Company, in advance of Final Adjudication, all Defense
Costs as incurred by the Indemnitee in connection with any Claim for which right
to indemnification is applicable under this Agreement. Defense Costs shall be
paid by the Company not later than twenty (20) days after receipt by the Company
of a statement of expenses from the Indemnitee requesting such payment, which
request shall be supported by a statement of costs; provided, however, that, if
the Delaware General Corporation Law requires, an advancement of Defense Costs
incurred by the Indemnitee in the Indemnitee's capacity as a director or officer
(and not in any other capacity in which service was or is rendered by the
Indemnitee, including, without limitation, as an employee, manager, agent or for
service to an employee benefit plan) shall be made only upon delivery to the
Company of an undertaking (hereinafter an "Undertaking"), by or on behalf of the
Indemnitee, to repay all amounts so advanced if it shall ultimately be
determined by Final Adjudication that the Indemnitee is not entitled to be
indemnified for such Defense Costs under this Agreement or otherwise.

         4. Right of Indemnitee to Bring Suit. (a) If a claim by the Indemnitee
to the Company for indemnification under Section 2 of this Agreement is not paid
in full by the Company within thirty (30) days after a written claim has been
received by the Company, or if a claim by the Indemnitee to the Company for an
advancement of Defense Costs under Section 3 of this Agreement is not paid in
full within twenty (20) days as specified in Section 3, the Indemnitee may at
any time thereafter bring suit against the Company to recover the unpaid amount
of the claims.

                  (b) If the Indemnitee is successful in whole or in part in any
suit brought under Section 4(a), or in a suit brought by the Company to recover
an advancement of Defense Costs pursuant to the terms of an Undertaking, the
Indemnitee shall be entitled to be paid also all

<PAGE>

costs and expenses (including without limitation all reasonable attorneys' fees,
court costs, witness fees) of prosecuting or defending such suit.

                  (c) In any suit brought by the Indemnitee to enforce a right
to indemnification hereunder (but not in a suit brought by the Indemnitee to
enforce a right under Section 3 to an advancement of Defense Costs) it shall be
a defense that it has been determined by Final Adjudication that the Indemnitee
has not met any applicable standard for indemnification set forth in the
Delaware General Corporation Law.

                  (d) In any suit against the Indemnitee by the Company to
recover an advancement of Defense Costs pursuant to the terms of an Undertaking,
the Company shall be entitled to recover such Defense Costs only upon a Final
Adjudication that the Indemnitee has not met any applicable standard for
indemnification set forth in the Delaware General Corporation Law.

                  (e) Neither the failure of the Company (including its
directors who are not parties to such action, a committee of such directors,
independent legal counsel, or its stockholders) to have made a determination
prior to the commencement of such suit that indemnification of the Indemnitee is
proper in the circumstances because the Indemnitee has met the applicable
standard of conduct set forth in the Delaware General Corporation Law, nor an
actual determination by the Company (including its directors who are not parties
to such action, a committee of such directors, independent legal counsel, or its
stockholders) that the Indemnitee has not met such applicable standard of
conduct, shall create a presumption that the Indemnitee has not met the
applicable standard of conduct or, in the case of such a suit brought by the
Indemnitee, be a defense to such suit. In any suit brought by the Indemnitee to
enforce a right to indemnification or to an advancement of Defense Costs
hereunder, or by the Company to recover an advancement of Defense Costs pursuant
to the terms of an Undertaking, the burden of proving that the Indemnitee is not
entitled to be indemnified, or to such advancement of Defense Costs, under this
Agreement or otherwise, shall be on the Company by clear and convincing
evidence.

         5. Settlement. The Company shall have no obligation to indemnify the
Indemnitee under this Agreement for any amounts paid in full settlement and/or
compromise of any Claim that was effected without Company's prior written
consent. The Company shall not enter into any full settlement and/or compromise
of any Claim in any manner that would impose any Damages on the Indemnitee
without the Indemnitee's written consent. Neither the Company nor the Indemnitee
shall unreasonably withhold, condition or delay their consent to any proposed
settlement or compromise. The exercise of any right of consent or withholding of
consent under this Section 5 shall not affect, excuse, modify or relieve the
Company of any of its obligations under this Agreement.

         6. Maintenance of Insurance. (a) The Company hereby represents and
warrants that policies of directors' and officers' liability insurance
("D&O Insurance") have been purchased by the Company and that such policies are
in full force and effect. The Indemnitee acknowledges that he has been informed
of, and provided access to, the D&O Policies.

                  (b) The Company hereby covenants and agrees that, so long as
the

<PAGE>

Indemnitee shall continue to serve as a director or officer of the Company
and thereafter so long as the Indemnitee shall be subject to any possible claim
or threatened, pending or completed action, suit or proceeding, whether civil,
criminal or investigative, by reason of the fact that the Indemnitee was a
director or officer of the Company, the Company, subject to Section 2(d), shall
maintain in full force and effect D&O Insurance.

                  (c) In all policies of D&O Insurance, the Indemnitee shall be
named as an insured in such a manner as to provide the Indemnitee the same
rights and benefits, subject to the same limitations, as are accorded to the
Company's directors or officers most favorably insured by such policy.

                  (d) The Company shall have no obligation to maintain D&O
Insurance if the Company determines in good faith that such insurance is not
reasonably available, the premium costs for such insurance is disproportionate
to the amount of coverage provided, or the coverage provided by such insurance
is limited by exclusions so as to provide an insufficient benefit.

         7. Rights Not Exclusive. The rights provided hereunder shall not be
deemed exclusive of any other rights to which the Indemnitee may be entitled
under any statute, provision of Company's certificate of incorporation, bylaw,
agreement, vote of stockholders or of disinterested directors or otherwise, both
as to action in his official capacity and as to action in any other capacity,
and shall continue after the Indemnitee ceases to serve the Company as a
director, officer, employee as the case may be.

         8. Severability. In the event that any provision of this Agreement is
determined by a court to require the Company to do or to fail to do an act that
is in violation of applicable law, such provision shall be limited or modified
in its application to the minimum extent necessary to avoid a violation of law,
and, as so limited or modified, such provision and the balance of this Agreement
shall be enforceable in accordance with their terms.

         9. Choice of Law. This Agreement shall be governed by and construed and
enforced in accordance with the laws of the State of Delaware.

         10. Consent to jurisdiction. The Company and the Indemnitee each hereby
irrevocably consent to the jurisdiction of the courts of the State of Delaware
for all purposes in connection with any action or proceeding which arises out of
or relates to this Agreement and agree that any action instituted under this
Agreement shall be brought only in the state courts of the State of Delaware.

         11. Successor and Assigns. This Agreement shall be (i) binding upon all
successors and assigns of the Company (including any transferee of all or
substantially all of its assets and any successor by merger or otherwise by
operation of law) and (ii) shall be binding on and inure to the benefit of the
heirs, personal representatives and estate of the Indemnitee.

         12. Amendment or Waiver. No amendment, modification, termination or
cancellation of this Agreement shall be effective unless made in a writing
signed by each of the parties hereto, and no waiver of any provision hereunder
shall be effective unless in writing.

<PAGE>

                  IN WITNESS WHEREOF, the Company and the Indemnitee have
executed this Agreement as of the day and year first above written.

                              BioVeris Corporation

                              By:
                                 ---------------------------------------
                                 Name:  George V. Migausky
                                 Title:  Chief Financial Officer

                              ------------------------------------------
                              [Name]<PAGE>
                                                                   EXHIBIT 10.28

                              BIOVERIS CORPORATION
                         TERMINATION PROTECTION PROGRAM

Section 1. Definitions. The following terms shall have the meaning ascribed to
them:

      (A) "Applicable Bonus" shall mean the highest maximum annual bonus that
      was (or could have been under an established bonus plan) paid to a
      Participant in respect of any of the three full calendar years preceding
      or following a Change of Control.

      (B) "Base Salary" shall mean a Participant's annual base salary in effect
      on the date of the Change of Control or the date of termination, whichever
      is higher.

      (C) "Board" shall mean the board of directors of the Company.

      (D) "Cause" shall mean (i) the Participant's conviction of a felony, or
      (ii) either of the following that, in each case, results in demonstrable
      harm to the Company's financial condition or business reputation (I) the
      Participant's willful malfeasance or misconduct in relation to the
      performance of his/her duties to the Company, or (II) the Participant's
      repeated willful refusal to perform his/her duties.

      (E) "Change of Control" shall mean (i) any Person or Group, other than a
      Group of which an Excluded Person is a member, becoming the beneficial
      owner of 20% or more of the Company's then outstanding voting securities,
      (ii) any merger, consolidation, reorganization or similar transaction
      involving the Company, other than, in the case of any of the foregoing, a
      transaction in which the Company's shareholders immediately prior to the
      transaction hold immediately thereafter, in the same proportion as
      immediately prior to the transaction, not less than a majority of the
      combined voting power of the then outstanding voting securities with
      respect to the election of the board of directors of the resulting entity,
      (iii) any change in a majority of the Board within a 24 month period
      (unless the change was approved by 2/3 of the Incumbent Directors), (iv)
      any liquidation or sale of all or substantially all of the Company's
      assets, provided that no grant to a third party of a license to use
      intellectual property made on an arm's length basis shall constitute a
      Change of Control, or (v) any other transaction so defined by the Board.

      (F) "Code" shall mean the Internal Revenue Code of 1986, as amended, and,
      as applicable, the regulations promulgated thereunder.

      (G) "Company" shall mean BioVeris Corporation, and, after a Change of
      Control, any successor or successors thereto.

      (H) "Compensation" shall mean the sum of a Participant's Applicable Bonus
      and Base Salary.

      (I) "Employee Benefits" shall mean, except as otherwise specified by the
      Chief Executive Officer of the Company with respect to a Participant at
      the time such Participant is designated as a Participant, the employee and
      fringe benefits and perquisites (including without limitation all medical,
      dental, life insurance, disability and pension (including maximum matching

<PAGE>

      contributions) benefits) made available to a Participant (and his or her
      eligible dependents) immediately prior to a Change of Control (or the
      economic equivalent thereof where pension laws prohibit or restrict such
      benefits).

      (J) "Excluded Person" shall mean Samuel J. Wohlstadter, Nadine
      Wohlstadter, their respective "Affiliates" or "Associates" (each as
      defined in Rule 12b-2 under the Exchange Act), their respective heirs and
      any trust or foundation to which either of them have transferred or may
      transfer the Company's voting securities.

      (K) "Exchange Act" shall mean the Securities Exchange Act of 1934, as
      amended.

      (L) "Good Reason" shall mean, except as otherwise specified by the Chief
      Executive Officer of the Company at the time a Participant is designated
      as a Participant (provided that such exception does not adversely affect
      such Participant), with respect to such a Participant, (i) a decrease in
      (or failure to increase in accordance with the terms of any employment
      contract) the Participant's base salary or bonus opportunity, (ii) a
      diminution in the aggregate employee benefits and perquisites provided to
      the Participant, (iii) a diminution in the Participant's title, reporting
      relationship, duties or responsibilities, (iv) relocation of the
      Participant's primary office more than 35 miles from its current location,
      or (v) the failure by any successor to the Company to explicitly assume
      this Program and the Company's obligations hereunder.

      (M) "Gross-Up Payment" shall have the meaning ascribed to such term in
      Section 4.

      (N) "Group" shall have the meaning ascribed to such term in the Exchange
      Act.

      (O) "Incumbent Director" shall mean a member of the Board on the date this
      Program was adopted together with any director who is appointed as a
      member of the Board, or who is nominated to become a member of the Board
      by, or with the approval of, at least 2/3 of the directors who qualified
      as Incumbent Directors at the time of such appointment or nomination.

      (P) "Participant" shall mean an employee of the Company designated by the
      Chief Executive Officer of the Company to participate in this Program.
      Once so designated, a Participant's rights hereunder may not be diminished
      unless such Participant's employment with the Company is terminated in a
      manner that will not permit him or her to become eligible for any payments
      hereunder.

      (Q) "Person" shall have the meaning ascribed to such term in the Exchange
      Act.

      (R) "Program" shall mean this Termination Protection Program, as it may be
      amended from time to time.

      (S) "Severance Payments" shall have the meaning ascribed to such term in
      Section 4.

      (T) "Total Payments" shall have the meaning ascribed to such term in
      Section 4.

Section 2. Term. This Program shall be effective as of the Effective Date, as
defined in the Agreement and Plan Merger dated as of July 24, 2003 among Roche
Holding Ltd, 66 Acquisition Corporation II, IGEN International, Inc. and IGEN
Integrated Healthcare, LLC, and shall continue in effect through

<PAGE>

December 31, 2006; provided, however, that, commencing on December 31, 2006, and
on each December 31 thereafter, this Program shall be automatically extended for
one additional year unless, not later than October 31 of such year, the Company
provides written notice to each Participant that this Program shall not be so
extended. In addition, if this Program is in effect on the date of a Change of
Control, then it shall continue in effect for not less than three years
following such Change of Control.

Section 3. Termination Protection. If during the term of this Program

      (a)   a Participant's employment with the Company is terminated by the
            Company without Cause, or a Participant resigns for Good Reason, in
            each case within thirty months following a Change of Control, or

      (b)   a Participant's employment with the Company is terminated prior to a
            Change of Control (which subsequently occurs) at the request of a
            party involved in such Change of Control, or otherwise in connection
            with or in anticipation of a Change of Control,

then in the case of each of clauses (a) and (b) such Participant shall become
entitled to the following compensation, benefits and rights, except as otherwise
specified by the Chief Executive Officer of the Company with respect to a
Participant at the time such Participant is designated as a Participant:

      (i) A cash lump sum, payable within ten days following the date of
      termination, equal to the sum of: (A) such Participant's pro rata target
      annual bonus in respect of the year of termination, (B) any unpaid Base
      Salary through the date of termination, (C) any bonus earned but unpaid as
      of the date of termination for any previously completed year, (D) all
      compensation previously deferred but not yet paid (except as otherwise
      agreed by such Participant), (E) reimbursement for any unreimbursed
      expenses incurred by such Participant prior to the date of termination,
      and (F) except as otherwise specified by the Chief Executive Officer of
      the Company, an amount equal to 150% of such Participant's Compensation.

      (ii) Such employee and fringe benefits and perquisites, if any, to which
      such Participant may be entitled as of the date of termination under the
      relevant plans, policies and programs of the Company.

      (iii) Any unvested Company stock options held by such Participant that are
      outstanding on the date of termination shall become fully vested as of
      such date, and all Company stock options held by such Participant that are
      outstanding on such date shall remain exercisable for two years following
      such date (or, if longer, until the date such options would otherwise
      terminate).

      (iv) Except as otherwise specified by the Chief Executive Officer of the
      Company with respect to a Participant at the time such Participant is
      designated as a Participant, continued eligibility for such Participant
      and his/her eligible dependents to receive Employee Benefits, for a period
      of 18 months following such Participant's date of termination, except
      where the provision of such Employee Benefits would result in a
      duplication of benefits provided by any subsequent employer.

<PAGE>

      (v) Reimbursement of all reasonable expenses incurred by such Participant
      within 18 months following such Participant's date of termination for
      professional outplacement services (provided by consultants selected by
      such Participant) and employment search activities.

      (vi) The amounts specified in Section 4.

      (vii) All rights such Participant has to indemnification from the Company
      immediately prior to the Change of Control shall be retained for the
      maximum period permitted by applicable law, and any director's and
      officer's liability insurance covering such Participant immediately prior
      to the Change of Control shall be continued throughout the period of any
      applicable statute of limitations.

      (viii) The Company shall advance to such Participant all costs and
      expenses, including all attorneys' fees and disbursements, incurred by
      such Participant in connection with any legal proceedings (including
      arbitration), which relate to the termination of employment or the
      interpretation or enforcement of any provision of this Program, and the
      Participant shall have no obligation to reimburse the Company for any
      amounts advanced hereunder where such Participant prevails in such
      proceeding with respect to at least one material issue, it being
      acknowledged that settlement of any such proceeding shall relieve the
      Participant from any reimbursement obligation.

Section 4. Excise Tax Gross-Up. In the event a Participant becomes entitled to
any amounts or benefits payable in connection with a Change of Control (whether
or not such amounts are payable pursuant to this Program) (the "Severance
Payments"), if any of such Severance Payments are subject to the tax (the
"Excise Tax") imposed by Section 4999 of the Code (or any similar federal, state
or local tax that may hereafter be imposed), the Company shall pay to such
Participant within ten days following the date of his/her termination of
employment an additional amount (the "Gross-Up Payment") such that the net
amount retained by such Participant, after deduction of any Excise Tax on the
Total Payments (as hereinafter defined) and any federal, state and local income
tax and Excise Tax upon the payment provided for by this Section, shall be equal
to the Total Payments. For purposes of determining whether any of the Severance
Payments will be subject to the Excise Tax and the amount of such Excise Tax:
(a) any other payments or benefits received or to be received by such
Participant in connection with a Change of Control or such Participant's
termination of employment (whether pursuant to the terms of this Program or any
other plan, arrangement or agreement with the Company, any entity whose actions
result in a Change of Control or any entity affiliated with the Company, or such
entity) (which, together with the Severance Payments, constitute the "Total
Payments") shall be treated as "parachute payments" within the meaning of
Section 280G of the Code, and all "excess parachute payments" within the meaning
of Section 280G of the Code shall be treated as subject to the Excise Tax,
unless in the opinion of a nationally-recognized tax counsel selected by such
Participant such other payments or benefits (in whole or in part) do not
constitute parachute payments, or such excess parachute payments (in whole or in
part) represent reasonable compensation for services actually rendered within
the meaning of Section 280G of the Code, or are otherwise not subject to the
Excise Tax, (b) the amount of the Total Payments which shall be treated as
subject to the Excise Tax shall be equal to the lesser of (i) the total amount
of the Total Payments and (ii) the amount of excess parachute payments within
the meaning of section 280G of the Code, and (c) the value of any non-cash
benefits or any deferred payments or benefits shall be determined by a
nationally-recognized accounting firm selected by such Participant in accordance
with the principles of Sections 280G of the Code. For purposes of determining
the amount of the Gross-Up Payment, such Participant shall be deemed to

<PAGE>

pay federal income taxes at the highest marginal rate of federal income taxation
in the calendar year in which the Gross-Up Payment is to be made and state and
local income taxes at the highest marginal rate of taxation in the state and
locality of such Participant's residence on his/her date of termination, net of
the maximum reduction in federal income taxes which could be obtained from
deduction of such state and local taxes. In the event that the Excise Tax is
determined to exceed the amount taken into account hereunder at the time of the
termination of such Participant's employment (including by reason of any payment
or benefit the existence or amount of which cannot be determined at the time of
the Gross-Up Payment), the Company shall make an additional gross-up payment in
respect of such excess within ten days after the time that the amount of such
excess is finally determined.

Section 5. No Mitigation or Offset. Except as provided in Section 3(iv), a
Participant shall not be required to mitigate the amount of any payment or
benefit provided for under this Program by seeking other employment or
otherwise, nor shall the amount of any payment or benefit provided for hereunder
be reduced by any compensation or benefits earned or received by such
Participant as the result of employment by a subsequent employer, by retirement
benefits, by offset against any amount claimed to be owed by such Participant to
the Company or otherwise.

Section 6. Validity. The invalidity or unenforceability of any provision of this
Program shall not affect the validity or enforceability of any other provision
of this Program, which other provision shall remain in full force and effect.

Section 7. Withholding. All payments hereunder shall be reduced by any
applicable taxes required by applicable law to be paid or withheld by the
Company.

Section 8. Modification or Waiver. No provision of this Program may be modified,
waived or discharged, unless such waiver, modification, or discharge is agreed
to in writing and signed by any Participant whose rights hereunder would be
adversely affected thereby.

Section 9. Applicable Law. This Program shall be governed by and construed in
accordance with the laws of the State of Maryland, without regard to conflicts
of laws principles thereof.

Section 10. No Liability. Neither the Board nor the Chief Executive Officer of
the Company shall have any liability for any decision made in good faith in
interpreting, implementing or operating this Program, including without
limitation, any changes made to the definition Good Reason, in establishing the
list of Participants, or in selecting the Participants to be included in any of
the Appendices attached to this Program. The Company hereby agrees to indemnify
and hold harmless each member of the Board and each officer, including without
limitation the Chief Executive Officer of the Company, for (and in each case,
advance) any and all costs and expenses incurred in connection with the
administration, operation and implementation of the Program, including without
limitation any changes made to the definition Good Reason, in establishing the
list of Participants, or in selecting the Participants to be included in any of
the Appendices attached to this Program. No amounts paid under this Section 10
for or on account of any of the foregoing officers or directors shall be
included in Compensation under this Program.

<PAGE>

                                ADDENDUM I TO THE
                              BIOVERIS CORPORATION
                         TERMINATION PROTECTION PROGRAM

1. The Chief Executive Officer of the Company may designate up to [39] employees
of the Company to participate in the Program at any particular time, on the
basis of name, title, function, or compensation level. The Chief Executive
Officer of the Company shall at all times be a Participant and shall have no
less favorable rights under the Program than any other Participant. As of
Effective Date the employees specified on Appendix A shall constitute the
Participants.

2. The Chief Executive Officer of the Company may designate, with respect to up
to [4] Participants, that any reason for resigning within the thirty day period
following the first anniversary of a Change of Control shall also constitute
"Good Reason." As of the Effective Date the Participants identified on Appendix
B have been so designated.

3. The Chief Executive Officer of the Company may designate, with respect to up
to [39] Participants, that "Employee Benefits" shall also include an annual
comprehensive physical/check-up. As of the Effective Date the Participants
identified on Appendix C have been so designated.

4. The Chief Executive Officer of the Company may designate, with respect to up
to [4] Participants, that the percentage specified in Section 3(i)(F) shall be
300% rather than 150%. As of the Effective Date the Participants identified on
Appendix D have been so designated.

5. The Chief Executive Officer of the Company may designate, with respect to up
to [6] Participants, that the percentage specified in Section 3(i)(F) shall be
200 percent rather than 150 percent. As of the Effective Date the Participants
identified on Appendix E have been so designated.

6. The Chief Executive Officer of the Company may designate, with respect to up
to [4] Participants, that the period specified in Section 3(iv) shall be,
instead of 18 months, life (with respect to medical and dental benefits and the
annual comprehensive physical/check-up) and 36 months (with respect to all other
coverages). As of the Effective Date the Participants identified on Appendix F
have been so designated.

7. The Chief Executive Officer of the Company may designate, with respect to up
to [39] Participants, that the period specified in Section 3(iv) shall be 24
months instead of 18 months. As of the Effective Date the Participants
identified on Appendix G have been so designated.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00057-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00057-of-00352.parquet"}]]